Ponesimod Compared with Teriflunomide in Patients with Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

Ludwig Kappos*, Robert J. Fox, Michel Burcklen, Mark S. Freedman, Eva K. Havrdová, Brian Hennessy, Reinhard Hohlfeld, Fred Lublin, Xavier Montalban, Carlo Pozzilli, Tatiana Scherz, Daniele D'Ambrosio, Philippe Linscheid, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Hilke Kracker, Till Sprenger

*Autor corresponent d’aquest treball

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

161 Cites (Scopus)

Fingerprint

Navegar pels temes de recerca de 'Ponesimod Compared with Teriflunomide in Patients with Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial'. Junts formen un fingerprint únic.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science